Jill DeSimone
Director/Board Member chez PRAXIS PRECISION MEDICINES, INC.
Fortune : 59 816 $ au 31/03/2024
Profil
Jill DeSimone is an Independent Director at Praxis Precision Medicines, Inc., Oncternal Therapeutics, Inc., Affini-T Therapeutics, Inc., Florida Cancer Specialists Foundation, Inc., and iTeos Therapeutics, Inc. She previously worked as a Director at The Children's Health Fund and as an Independent Director at Kinnate Biopharma, Inc. She also held the position of Senior Vice President-US Commercial at Bristol Myers Squibb Co. from 2010 to 2012.
Additionally, she served as Senior Vice President & General Manager at Teva Women's Health, Inc. and as President-US Oncology at Merck & Co., Inc. from 2014 to 2022.
She was also Senior Vice President-Global Women Health at Teva Pharmaceutical Industries Ltd.
from 2012 to 2014.
Ms. DeSimone completed her undergraduate degree at Northeastern University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/10/2023 | 967 ( 0,01% ) | 59 006 $ | 31/03/2024 | |
| 28/06/2023 | 90 ( 0,00% ) | 810 $ | 31/03/2024 | |
KINNATE BIOPHARMA, INC.
-.--% | 03/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jill DeSimone
| Sociétés | Poste | Début |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Director/Board Member | 23/05/2022 |
| ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 03/01/2023 |
| ITEOS THERAPEUTICS, INC. | Director/Board Member | 07/03/2024 |
| Florida Cancer Specialists Foundation, Inc. | Director/Board Member | 01/04/2022 |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Director/Board Member | 12/07/2022 |
Anciens postes connus de Jill DeSimone
| Sociétés | Poste | Fin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Director/Board Member | 03/04/2024 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/05/2022 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2014 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2012 |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Jill DeSimone
| Northeastern University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Teva Women's Health, Inc.
 Teva Women's Health, Inc. Pharmaceuticals: MajorHealth Technology Teva Women's Health, Inc. produces a wide range of women’s healthcare products. Its products include oral contraceptives, intrauterine contraception, and hormone therapy treatments for menopause. The company is headquartered in Woodcliff Lake, NJ. | Health Technology |
The Children's Health Fund
 The Children's Health Fund Medical/Nursing ServicesHealth Services The Children's Health Fund is a non-profit organization, which engages in the provision of healthcare services for kids. It offers Blue Bus, a pediatric mobile medical clinic that offers curbside checkups and treatments. The firm also supports the Terra Firma project, a program the provides healthcare, mental health support, and legal assistance for unaccompanied immigrant minors. The company was founded by Irwin E. Redlener, Karen B. Redlener, and Paul Simon in 1987 and is headquartered in New York, NY. | Health Services |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Health Technology |
| Florida Cancer Specialists Foundation, Inc. |
